Biotech ETFs: Fidelity Biotech Fund Outperforms Ibb But Xbi Is Still The Leader

Biotech stocks have outperformed the market YTD despite a bit of a sell-off recently. After two severe corrections in 2016 the Fidelity Select Biotechnology Fund has begun to emerge as a good play for less volatile larger caps in the sector.